tradingkey.logo

Polyrizon Ltd

PLRZ
13.250USD
+0.405+3.15%
收盘 02/09, 16:00美东报价延迟15分钟
55.58M总市值
亏损市盈率 TTM

Polyrizon Ltd

13.250
+0.405+3.15%

关于 Polyrizon Ltd 公司

Polyrizon Ltd is an Israel-based biotechnology company. The Company is primarily engaged and specializing in the development of medical device hydrogels delivered in the form of nasal sprays, which form a thin hydrogel-based shield containment barrier in the nasal cavity that can provide a barrier against viruses and allergens from contacting the nasal epithelial tissue. Its naturally occurring building blocks, is delivered in the form of nasal sprays, and potentially functions as a biological mask with a thin shield containment barrier in the nasal cavity. The Company is focused not only on the development of intranasal products, but also on commercialization. The Company cooperates with medical specialists and researchers..

Polyrizon Ltd简介

公司代码PLRZ
公司名称Polyrizon Ltd
上市日期Oct 29, 2024
CEOIzraeli (Tomer)
员工数量1
证券类型Ordinary Share
年结日Oct 29
公司地址HaTidhar St. 5
城市RA'ANANA
上市交易所NASDAQ OMX - NASDAQ BASIC
国家Israel
邮编- -
电话97293740120
网址https://polyrizon-biotech.com/
公司代码PLRZ
上市日期Oct 29, 2024
CEOIzraeli (Tomer)

Polyrizon Ltd公司高管

名称
名称/职务
职务
持股
持股变动
Mr. Tomer Izraeli
Mr. Tomer Izraeli
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
--
Mr. Nir Ben Yosef
Mr. Nir Ben Yosef
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Eyal S. Ron, Ph.D.
Dr. Eyal S. Ron, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Dr. Tidhar Turgeman
Dr. Tidhar Turgeman
Chief Technology Officer
Chief Technology Officer
--
--
Ms. Daphna Avital
Ms. Daphna Avital
Chief People Officer
Chief People Officer
--
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
--
--
Mr. Oz Adler, CPA
Mr. Oz Adler, CPA
Director
Director
--
--
Mr. Omer Srugo
Mr. Omer Srugo
Independent Director
Independent Director
--
--
Ms. Liat Sidi
Ms. Liat Sidi
Independent Director
Independent Director
--
--
Mr. Yehonatan Zalman Vinokur
Mr. Yehonatan Zalman Vinokur
Independent Director
Independent Director
--
--
查看更多
名称
名称/职务
职务
持股
持股变动
Mr. Tomer Izraeli
Mr. Tomer Izraeli
Chief Executive Officer, Director
Chief Executive Officer, Director
8.00
--
Mr. Nir Ben Yosef
Mr. Nir Ben Yosef
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Eyal S. Ron, Ph.D.
Dr. Eyal S. Ron, Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Dr. Tidhar Turgeman
Dr. Tidhar Turgeman
Chief Technology Officer
Chief Technology Officer
--
--
Ms. Daphna Avital
Ms. Daphna Avital
Chief People Officer
Chief People Officer
--
--
Mr. Asaf Itzhaik
Mr. Asaf Itzhaik
Independent Director
Independent Director
--
--

收入明细

由于公司未披露,未能获取相关数据
由于公司未披露,未能获取相关数据
业务
地区
由于公司未披露,未能获取相关数据

股东统计

更新时间: 12月17日 周三
更新时间: 12月17日 周三
持股股东
股东类型
持股股东
持股股东
占比
L.I.A. Pure Capital Ltd
9.99%
Eli (Zamir)
9.99%
UBS Financial Services, Inc.
0.06%
其他
79.96%
持股股东
持股股东
占比
L.I.A. Pure Capital Ltd
9.99%
Eli (Zamir)
9.99%
UBS Financial Services, Inc.
0.06%
其他
79.96%
股东类型
持股股东
占比
Individual Investor
10.00%
Corporation
9.99%
Investment Advisor
0.06%
其他
79.95%

机构持股

更新时间: 1月1日 周四
更新时间: 1月1日 周四
报告期
机构数
持股数
持股占比
持股变动
2025Q4
10
1.04K
0.07%
-57.85K
2025Q3
10
370.57K
6.19%
+370.41K
2025Q2
15
715.00
0.01%
-142.00
2025Q1
18
1.04K
18.49%
+190.00
2024Q4
14
2.89M
68.88%
+2.89M

股东持股明细

名称
持股数
占比
持股变动
变动比例
公告日期
L.I.A. Pure Capital Ltd
159.24K
9.99%
+159.22K
+1592250.00%
Dec 05, 2025
Eli (Zamir)
159.24K
9.99%
+159.24K
--
Dec 05, 2025
UBS Financial Services, Inc.
2.04K
0.13%
-2.89K
-58.54%
Sep 30, 2025
Srugo (Raul)
21.00
0%
-2.00
-8.70%
Mar 10, 2025
Srugo (Itzhak)
20.00
0%
-3.00
-13.04%
Mar 10, 2025
Srugo (Yoav)
19.00
0%
-4.00
-17.39%
Mar 10, 2025
Srugo (Sofi Yochelman)
19.00
0%
--
--
Mar 10, 2025
Citi Investment Research (US)
19.00
0%
-66.00
-77.65%
Sep 30, 2025
Izraeli (Tomer)
8.00
0%
--
--
Mar 10, 2025
Scisparc
--
0%
-21.00
-100.00%
Mar 10, 2025
查看更多

持股ETF

机构名称
占比
暂无数据

分红派息

近5年累计派现 0.00 美元
公告日期
分红计划
股权登记日
现金发放日
除权除息日
暂无数据

拆合股

公告日期
除权除息日
类型
比率
May 22, 2025
Merger
250→1
公告日期
除权除息日
类型
比率
May 22, 2025
Merger
250→1
KeyAI